The latest news in cancer research, health and policy by Cancer Research UK.
We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy.
A new drug that has passed safety tests in adults is likely to be effective against the aggressive childhood cancer neuroblastoma.
A targeted cancer drug, already licensed for treating some breast and ovarian cancers, is found to be effective for some men with advanced prostate cancer.
Scientists have a developed a new technique to decipher how millions of cells are communicating with each other in miniature tumours grown in the lab.
Cancer Research UK announces the signing of a five-year drug-discovery collaboration between its subsidiary, Cancer Research Technology, and Celgene Corporation
An ovarian cancer drug can leak through the blood brain barrier to reach brain tumours and could be an effective treatment for glioblastoma.
Two clinical trials have found that existing treatments for advanced melanoma could stop the cancer returning in some people with earlier stage disease.
Cancer Research UK and Biotecnol Limited will trial an experimental immuno-oncology treatment for some patients with advanced tumours.
Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent.
A drug holds lung cancer at bay longer after surgery than standard chemotherapy, according to unpublished results of a new trial in China.
Immunotherapy treatment could be improved by blocking molecules that help tumour blood vessels grow, according to two new lab-based studies.